Fady Ibraham Malik - 22 Dec 2025 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
EVP Research & Development
Signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Malik
Issuer symbol
CYTK
Transactions as of
22 Dec 2025
Net transactions value
-$63,724
Form type
4
Filing time
29 Dec 2025, 16:06:38 UTC
Previous filing
16 Dec 2025
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Malik Fady Ibraham EVP Research & Development 350 OYSTER POINT BLVD, SOUTH SAN FRANCISCO /s/ John O. Faurescu, attorney-in-fact for Dr. Malik 24 Dec 2025 0001551778

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Award $0 +2,000 +1.4% $0.000000 140,552 22 Dec 2025 Direct F1
transaction CYTK Common Stock Award $0 +2,000 +1.4% $0.000000 142,552 22 Dec 2025 Direct F2
transaction CYTK Common Stock Tax liability $63,724 -1,016 -0.71% $62.72 141,536 22 Dec 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance shares earned upon achieving performance goal. Shares remain subject to 1-year time vesting requirement.
F2 Performance shares earned upon achieving performance goal. Shares vested immediately.
F3 Withholding of shares for tax withholding on vesting of performance shares.